It's July 1, which means a new edition of #TheAxon is hot off the press! Check out what our team has been following this past month in neurology.
About us
Neurology Live is your trusted news source for breaking drug approvals, pipeline trials and emerging trends in neurology. The digital and print publication provides physicians and other healthcare professionals with up-to-date disease-specific news, clinical information and other resources that can help them provide better care to patients. At Neurology Live, you'll find in-depth conference coverage and information about upcoming meetings, content from our affiliated print journals, video interviews with leading physician experts and other multimedia resources. Get all the latest news on individual medical conditions in our condition centers: • Dementia & Alzheimer Disease • Epilepsy • Headache & Migraine • Movement Disorders • Multiple Sclerosis • Neuromuscular • Sleep Medicine • Stroke
- Website
-
http://neurologylive.com/
External link for NeurologyLive
- Industry
- Online Audio and Video Media
- Company size
- 201-500 employees
- Headquarters
- Cranbury, New Jersey
- Type
- Privately Held
- Specialties
- Dementia, Alzheimer Disease, Epilepsy, Migraine, Headache, Movement Disorders, Parkinson Disease, Huntington Disease, Tardive Dyskinesia, Multiple Sclerosis, Sleep Medicine, Stroke, and Neuromuscular
Locations
-
Primary
2 Clarke Dr
Cranbury, New Jersey 08512, US
Employees at NeurologyLive
Updates
-
In episode 14 of this Peer Exchange video series, titled "Managing Spinal Muscular Atrophy in Adult Patients," experts explored the challenges and considerations associated with patients with #SMA transitioning to independent living. 🎥 View Now: https://lnkd.in/exEZiUFZ
-
-
Take 5️⃣ minutes to stay up-to-date with our #FridayFive today! 🖐 https://lnkd.in/eJPEcNTr
-
-
In episode 8 of this Peer Exchange video series, titled "Therapeutic Options and Clinical Considerations in the Management of Spasticity," a panel of experts discuss ITB use in #spasticity treatment. 📺 Watch Now: https://lnkd.in/eX8eNvT4
-
-
🗣️🎙️In a new NeuroVoices, David Shprecher, DO, MSci, FAAN, Banner Health, talked about recent, promising advancements for diagnosing atypical Parkinsonian disorders and the questions that remain. #ATMRD24 PMD Alliance (Parkinson & Movement Disorder Alliance) 📘 Read more: https://lnkd.in/eCU6CwCu
-
-
NeurologyLive reposted this
Sameea Husain Wilson, D.O, a neurologist at Marcus Neuroscience Institute, Baptist Health in Boca Raton, Florida, recently released a NeurologyLive video where she gives an overview of the biopsy procedure for the Syn-One Test® and describes how the test results inform her next steps, allowing her to tailor her approach to patient care. Watch the video here. https://lnkd.in/guzDd9kR Rick Morello Todd Levine CND Life Sciences #parkinsons #ParkinsonsDisease #DementiaWithLewyBodies #alphasynuclein
-
-
🗣️🎙️Today we had a fantastic conversation with Anna Castagna, MD, of Fondazione Don Gnocchi, who spoke about a review of the duration of botulinum toxin efficacy in cervical dystonia clinical trials presented at #ATMRD24! Stay tuned for the interview! 🧠 🇮🇹 PMD Alliance (Parkinson & Movement Disorder Alliance) #MovementDisorders #ATMRDCongress #CervicalDystonia #PMDAlliance
-
-
NeurologyLive reposted this
One of our poster winners at #ATMRD24! Congratulations Patti Clark.
Patricia Clark, CNP, of Cleveland Clinic, talked about a specialized program for hospitalized patients with #ParkinsonDisease that aligns hospital protocols with their home medication regimens to improve their care. #ATMRDCongress #PMDAlliance #AdvancedTherapeutic #Neurology #Neuroscience #MovementDisorders #ATMRD24 PMD Alliance (Parkinson & Movement Disorder Alliance) View here 👉 https://lnkd.in/ggXqmPaB
-
-
Martin Tolar, MD, PhD, of Alzheon, Inc. | Preserving Future Memories, talked about the implications of early diagnosis and intervention for patients in the pre-symptomatic stages of other neurodegenerative diseases besides #AlzheimerDisease. https://lnkd.in/eA55sK4Y
Altering Alzheimer Care Landscape With New, Advanced Therapeutics: Martin Tolar, MD, PhD
neurologylive.com
-
New data from a multiple-ascending dose portion of the open-label, phase 1/2 HALOS study showed a resounding number of patients with #AngelmanSyndrome who had improvements in overall symptoms following treatment with investigational ION582. Ionis Pharmaceuticals, Inc. https://lnkd.in/eVM2Umuw
Ionis to Advance ION582 in Phase 3 Studies of Angelman Syndrome Following Positive Open-Label Data
neurologylive.com